Skip to content

Axium™ MicroFX™ for Endovascular Repair of IntraCranial Aneurysm-A Multicenter Study

Axium™ MicroFX™ for Endovascular Repair of IntraCranial Aneurysm-A Multicenter Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01323439
Acronym
AMERICA
Enrollment
99
Registered
2011-03-25
Start date
2010-04-30
Completion date
2012-10-31
Last updated
2017-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysm

Keywords

Patients presenting with an intracranial aneurysm

Brief summary

This is a multicenter, prospective single-arm trial evaluating the safety and efficacy of the Axium MicroFX coil system in 100 aneurysms.

Detailed description

This is a multicenter, prospective single-arm trial evaluating the safety and efficacy of the Axium MicroFX coil system in 99 patients at 13 study centers. The primary endpoint of the trial was the anatomic occlusion of the aneurysm in the immediate post-procedure angiogram basedon the Raymond classification. Secondary endpoints included safety during the procedure, safety after the procedure, detachment system performance, stability of the embolization, and packing efficacy.

Interventions

DEVICEAxium™ MicroFX™ PGLA COILS

Axium™ MicroFX™ PGLA COILS to treat aneurysms

Sponsors

University of Florida
CollaboratorOTHER
Medtronic Neurovascular Clinical Affairs
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of one or more intracranial aneurysm, either ruptured or unruptured. * Information on data collection provided to the patient or legally authorized representative and signed informed consent. * Aneurysm diameter ≤10mm . * Age range of 18 - 90.

Exclusion criteria

* Aneurysm previously treated. * Aneurysm AVM related or dissecting. * Participation in a clinical investigation of other aneurysm treating or related devices. * Any condition that would preclude the conduct of protocol follow-up. * Aneurysm anatomy that is determined inappropriate for Axium coil placement, prior to opening of an Axium coil.

Design outcomes

Primary

MeasureTime frameDescription
Anatomic occlusion of the aneurysmImmediately post-procedureOcclusion of aneurysm based on the Raymond classification

Secondary

MeasureTime frameDescription
Safety during the procedureDischarge, up to two yearsMorbidity and mortality rate
Safety post-procedure3-6 months follow-upMorbidity and mortality rate
Detachment system performanceDuring procedureOccurrence of detachment failure
Stability of embolization3-6 months follow-upRate of change towards worsening Raymond grades
Packing efficacy36- months follow-upincrease in packing density calculated as ration between volume of coils and the aneurysm volume

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026